多替阿巴拉米片在国内售价多少？

(Dotiabalamid Tablets) is a complete single-tablet three-in-one preparation with DTG as the core. It can be taken once a day, one pill at a time, without considering factors such as food, environment, location, etc. AIDS is generally recognized as a chronic disease. “For chronic diseases, patient compliance is particularly important. Taking one pill once a day reduces the frequency and dosage of medication and significantly enhances patient compliance.

How much does Suimeikai (Doteta abalami tablets) cost in China?

In my country, the current AIDS drugs are mainly free drugs from the state. However, the types of drugs covered by the "Free Catalog" cannot meet the needs of Chinese patients. Of the more than 20 anti-AIDS drugs currently on the market in China, only 8 are included in the "Free Catalog". AIDS is generally treated as a chronic disease, and the treatment period is long. The eight drugs in the free catalog cannot cover all AIDS patients. However, whether it is self-paid medicine or free medicine, it is a beneficial and harmless thing to fill the gap in medication and give patients one more choice.

The current price of Suimeikai (Doteta Abalamid Tablets) in the Chinese market is $2,880 per month, which has met the policy requirements and orientation of “the lowest in neighboring countries and regions”. AIDS is a very important treatment area for GSK, for which it has invested huge R&D expenses. GSK continues to innovate and introduce new products to China to meet the needs of Chinese patients for drugs, which is a very important development strategy for it. In the future, GSK will increase relevant clinical research in China.

At the same time, GSK launched a cooperation with the Beijing Red Ribbon House in December 2016. The cooperative project trains volunteers, including gay testing. It also cooperates with the Chinese Society of Preventive Medicine and other institutions to promote the improvement of AIDS prevention and control capabilities. In 2016, GSK established an institute of infectious diseases and public health in Beijing to conduct research on new drug development in China, including drugs for HIV prevention.

“GSK has established and expanded a professional academic promotion team to cooperate with the promotion of HIV drugs in China.” In Xu Ding’s logic, “improving the accessibility of drugs is an important task for GSK. To this end, GSK will continue to actively cooperate with the Chinese government in relevant work, whether it is now through free drug lists, medical insurance, or in the future through commercial medical insurance, or other effective ways to increase accessibility.

According to Medical Companion Travel, Inbec (Inbec), produced by the Indian company Emcure, is available in a box of 30 tablets and costs about RMB 1,000. It is much cheaper than domestically and is the most cost-effective version of Suimeike (Inbec) in the world.